(Q39743290)

14 September 2017

1 reference

title

Clinical pharmacokinetics of dapsone (English)

1 reference

14 September 2017

1 reference

J Zuidema

1

1 reference

14 September 2017

E S Hilbers-Modderman

series ordinal

2

1 reference

14 September 2017

F W Merkus

series ordinal

3

1 reference

14 September 2017

1 July 1986

1 reference

Clinical Pharmacokinetics

14 September 2017

1 reference

14 September 2017

11

1 reference

14 September 2017

4

1 reference

14 September 2017

299-315

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198611040-00003

14 September 2017

0 references

cites work

Some pitfalls in selecting descriptive pharmacokinetic models

1 reference

12 December 2020

Acetylator phenotyping: a comparison of the isoniazid and dapsone tests

1 reference

12 December 2020

Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage

1 reference

12 December 2020

Sulfonamides and sulfones in dermatologic therapy

1 reference

12 December 2020

N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans

1 reference

12 December 2020

Oral activated charcoal and dapsone elimination.

1 reference

12 December 2020

The protein binding of some drugs in plasma from patients with alcoholic liver disease

1 reference

12 December 2020

Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine

1 reference

12 December 2020

Studies of the metabolism of dapsone in man and experimental animals: formation of N-hydroxy metabolites

1 reference

12 December 2020

The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (DDS)

1 reference

12 December 2020

Absorption and excretion of 35S dapsone in dermatitis herpetiformis

1 reference

12 December 2020

Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients

1 reference

12 December 2020

Metabolism and haemolytic effect of dapsone and its metabolites in man

1 reference

12 December 2020

Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method

1 reference

12 December 2020

The polymorphic acetylation of dapsone in man

1 reference

12 December 2020

Radioactive tracer studies on uptake of di-amino-diphenyl-sulphone by leprosy patients.

1 reference

12 December 2020

[Use of diaminodiphenylsulfone in suspension in various vehicles in the treatment of leprosy]

1 reference

12 December 2020

Renal functional status in lepromatous leprosy

1 reference

12 December 2020

Dapsone assay based on Schiff base formation

1 reference

12 December 2020

A new analytical procedure for dapsone. Application to blood-level and urinary-excretion studies in normal men

1 reference

12 December 2020

Biochemical effects of aromatic amines. I. Methaemoglobinaemia, haemolysis and Heinz-body formation induced by 4,4'-diaminodiphenylsulphone.

1 reference

12 December 2020

Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin

1 reference

12 December 2020

Successful treatment of acute dapsone intoxication using charcoal hemoperfusion

1 reference

12 December 2020

Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution

1 reference

12 December 2020

A rapid method for determination of acetylation phenotype using dapsone

1 reference

12 December 2020

Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency

1 reference

12 December 2020

The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva

1 reference

12 December 2020

Application of Spectrophotofluorometric Procedures to Some Problems in Mycobacterium Leprae Infections in Mice and Man Treated with Dapsone (DDS), Diacetyl-DDS (DADDS), and Di-Formyl-DDS (DFD) *

1 reference

12 December 2020

Absorption, metabolism and excretion of di(rho-aminophenyl) sulphone (dapsone) and di(rho-aminophenyl) sulphoxide in man

1 reference

12 December 2020

Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS

1 reference

12 December 2020

An Injection Solution of Dapsone

1 reference

12 December 2020

The Disposition of Sulfoxone and Solasulfone in Leprosy Patients

1 reference

12 December 2020

The absorption of dapsone by patients with dermatitis herpetiformis and coeliac disease

1 reference

12 December 2020

Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation

1 reference

12 December 2020

Influence of disease on binding of drugs to plasma proteins

1 reference

12 December 2020

Inhibition of dapsone excretion by probenecid.

1 reference

12 December 2020

Patient compliance with dapsone administration in leprosy

1 reference

12 December 2020

1 reference

12 December 2020

Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients

1 reference

12 December 2020

Clinical consequences of polymorphic acetylation of basic drugs

1 reference

12 December 2020

Sex differences in the absorption of dapsone after intramuscular injection

1 reference

12 December 2020

The identification of the major diazotizable metabolite of 4:4'-diaminodiphenyl sulphone in rabbit urine

1 reference

12 December 2020

Adverse effects of dapsone

1 reference

12 December 2020

Methemoglobinemia Provoked by Malarial Chemoprophylaxis in Vietnam

1 reference

12 December 2020

Dapsone Metabolism in Patients with Dapsone-Resistant Leprosy

1 reference

12 December 2020

A review of therapeutic and hemolytic effects of dapsone

1 reference

12 December 2020

Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects dosed with maloprim

1 reference

12 December 2020

Pharmacokinetic observations on dapsone in dermatitis herpetiformis

1 reference

12 December 2020

Cimetidine and dapsone acetylation

1 reference

12 December 2020

Microsomal N-Oxidation of Dapsone as a Cause of Methemoglobin Formation in Human Red Cells *

1 reference

12 December 2020

The effect of rifampicin on dapsone metabolism

1 reference

12 December 2020

The Disposition of the Antileprotic Drug Dapsone (DDS) in Philippine Subjects *

1 reference

12 December 2020

Dapsone for AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

Intramuscular or intralipomatous injections?

1 reference

12 December 2020

The Haemolytic Action of Dapsone: The Effect on Red-Cell Glycolysis

1 reference

12 December 2020

Do anti-leprosy drugs reach Mycobacterium leprae in peripheral nerves?

1 reference

12 December 2020

The in Vitro Action of Dapsone and its Derivatives on Normal and G6PD-deficient Red Cells

1 reference

12 December 2020

The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves

1 reference

12 December 2020

New approaches to chemotherapy for leprosy

1 reference

12 December 2020

Mechanism of methemoglobin formation by diphenylsulfones. Effect of 4-amino-4'-hydroxyaminodiphenylsulfone and other p-substituted derivatives

1 reference

12 December 2020

Effect of dose on acetylator phenotype distribution of hydralazine

1 reference

12 December 2020

Dapsone in the treatment of miliary lupus of the face

1 reference

12 December 2020

Metabolic Disposition of Dapsone in African Leprosy Patients

1 reference

12 December 2020

Delayed sulfhemoglobinemia after acute dapsone intoxication.

1 reference

12 December 2020

A chromatographic-fluorometric procedure for the determination of nanogram quantities of antileprotic sulfones

1 reference

12 December 2020

Neonatal haemolytic disease due to dapsone

1 reference

12 December 2020

Disappearing N-hydroxy compounds

1 reference

12 December 2020

Polymorphic Acetylation of the Antibacterials, Sulfamethazine and Dapsone, in South Indian Subjects *

1 reference

12 December 2020

Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination

1 reference

12 December 2020

Acetylator phenotyping: the effect of ethanol on the dapsone test

1 reference

12 December 2020

Regression of Kaposi's sarcoma in AIDS after treatment with dapsone

1 reference

12 December 2020

Dapsone in saliva and plasma of man

1 reference

12 December 2020

1 reference

12 December 2020

Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype

1 reference

12 December 2020

Sustained release properties of an intra-adiposely administered dapsone depot injection

1 reference

12 December 2020

Pharmacogenetic polymorphism of drug metabolism

1 reference

12 December 2020

Study on drug interactions

1 reference

12 December 2020

Hemolytic anemia induced by dapsone transmitted through breast milk

1 reference

12 December 2020

The fluorometric measurement of 4,4'-diaminodiphenyl sulfone and its acetylated derivatives in plasma and urine

1 reference

12 December 2020

The pharmacology of sulphetrone and its implications in sulphone resistance

1 reference

12 December 2020

Sulfones and sulfonamides in dermatology today

1 reference

12 December 2020

[Plasma levels of DDS in leprosy patients admitted in the National Sanatorium Oshima Seisho-en]

1 reference

12 December 2020

Clearance concept in salivary drug excretion. Part II: Experiments

1 reference

12 December 2020

Injections into fat instead of muscle

1 reference

12 December 2020

Rapid high-performance liquid chromatographic method for the determination of dapsone and monoacetyldapsone in biological fluids

1 reference

12 December 2020

The incidence of DDS resistance in lepromatous patients in Costa Rica: their metabolic disposition of DDS

1 reference

12 December 2020

Clearance concept in salivary drug excretion. Part I: theory

1 reference

12 December 2020

Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents.

1 reference

12 December 2020

10.2165/00003088-198611040-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference